Ep192: Kate Haviland on Following the Science to Precision Immunology
The Long Run with Luke Timmerman
00:00
Pipeline Insights and Sanofi Discussions
Kate explains BD talks around the Blue-808 program and how Avapritinib plus pipeline interest led to Sanofi acquisition talks.
Play episode from 01:18:32
Transcript
